November 04, 2025

Get In Touch

Perioperative Aspirin Safe During Robotic Partial Nephrectomy: Study

Perioperative Aspirin Study

Perioperative Aspirin in Robotic Partial Nephrectomy

Perioperative aspirin is safe during robotic partial nephrectomy (RPN), according to a new study. However, more studies are needed to clarify the role of perioperative aspirin in robotic partial nephrectomy (RPN).

The study has been published in the Journal of Urology.

Daily aspirin use following cardiovascular intervention is commonplace and creates concern regarding bleeding risk in patients undergoing surgery. Despite its cardio-protective role, aspirin is often discontinued 5–7 days prior to major surgery due to bleeding concerns. Single institution studies have investigated perioperative outcomes of aspirin use in robotic partial nephrectomy (RPN). We sought to evaluate the outcomes of perioperative aspirin (pASA) use during RPN in a multicenter setting.

The researchers performed a retrospective evaluation of patients undergoing RPN at 5 high volume RPN institutions. We compared perioperative outcomes of patients taking perioperative aspirin (pASA) (81 mg) to those not on aspirin. They analyzed the association between perioperative aspirin (pASA) use and perioperative transfusion.

Results of the Study

  • Of 1,565 patients undergoing RPN, 228 (14.5%) patients continued perioperative aspirin (pASA) and were older (62.8 vs 56.8 years, p <0.001) with higher Charlson scores (mean 3 vs 2, p <0.001).
  • Perioperative aspirin (pASA) was associated with increased perioperative blood transfusions (11% vs 4%, p <0.001) and major complications (10% vs 3%, p <0.001).
  • On multivariable analysis, perioperative aspirin (pASA) was associated with increased transfusion risk (OR 1.94, 1.10–3.45, 95% CI).

Thus, the researchers concluded that in experienced hands, perioperative aspirin 81 mg use during RPN is reasonable and safe; however, there is a higher risk of blood transfusions and major complications. Future studies are needed to clarify the role of antiplatelet therapy in RPN patients requiring perioperative aspirin (pASA) for primary or secondary prevention of cardiovascular events.

Reference

Perioperative Aspirin Use Is Associated with Bleeding Complications during Robotic Partial Nephrectomy by Joan C. Delto et al. published in the Journal of Urology.

Read the full study

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!